Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
NCT05792722

Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy

Led by Johns Hopkins University · Updated on 2025-11-18

70

Participants Needed

2

Research Sites

296 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this clinical trial is to determine if prostate-capsule-sparing cystectomy improves functional outcomes without comprising oncologic outcomes in male patients receiving a radical cystectomy. Patients will be randomized to one of two groups: prostate capsule-sparing radical cystectomy or nerve-sparing radical cystectomy. Patients will be monitored following standard of care guidelines and clinical data will be collected. Patients in both groups will be asked to complete an erectile function questionnaire at multiple timepoints. Patients who receive an orthotopic neobladder will be asked to complete a questionnaire to monitor urinary function at multiple timepoints. Patient adverse events will be monitored to ensure patients safety.

CONDITIONS

Official Title

Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Pathologically confirmed bladder cancer and scheduled for radical cystectomy
  • Variant histologies of bladder cancer are allowed
  • Neoadjuvant therapy is permitted
  • Age over 18 years
  • Ability to understand and willing to sign informed consent
Not Eligible

You will not qualify if you...

  • Not a candidate for cystectomy
  • Moderate to severe erectile dysfunction with SHIM score less than 17
  • Bladder cancer involving bladder neck or prostate, including prostatic urethra cancer
  • Prior pelvic radiation
  • Confirmed prostate cancer or abnormal prostate exam or elevated PSA over 3
  • Increased genetic risk of prostate cancer per NCCN guidelines
  • Diagnosis of Lynch syndrome

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Sibley Memorial Hospital

Washington D.C., District of Columbia, United States, 20016

Actively Recruiting

2

Johns Hopkins Hospital

Baltimore, Maryland, United States, 21287

Actively Recruiting

Loading map...

Research Team

A

Armine Smith, MD

CONTACT

D

Domani Rodriguez

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here